Since the national COVID-19 outbreak in January 2020, BACME Biotech had been keeping an eye on the development of the epidemic, and quickly set up a special research and development team, worked overtime to develop the Novel Coronavirus test kit, with years of technical accumulation in the molecular field, successfully developed the Novel high sensitive Novel Coronavirus Nucleic Acid test kit, Novel Cronavirus (Sars-Cov-2) Nucleic Acid test can be realized quickly by using multiple fluorescence detection.
This kit can be used in vitro to qualitatively detect suspected cases of nCoV infection, patients with suspected clustering cases and other nCoV infection diagnostic or differential diagnostic such as ORF1ab, E-gene and N-gene in swab, sputum and alveolar lavage fluid samples.
【Operating Procedure】Specimen collection, inactivation → Sampling → Automated nucleic acid extraction → PCR fluorescence detection → Results of evaluation
Features & Benefits
1.More efficient: Triple genes detected in each single test (ORF1ab, E gene, N gene).
2.More accurate: The internal standard monitors the whole process of samples from sampling, storage, transportation, nucleic acid extraction to amplification and detection.
3.Safer: The quality control products of the kit are all made of genetically engineered virus-like materials to ensure the safety of laboratory operators.
4. Super sensitiveness for screening(3.2 copies/reaction,1a/b gene).
BACME Biotech as one of the few national leading enterprise that only focus on the field of in vitro diagnostic, always pay attention to the development of the outbreak of the world. We will also continue to focus on in vitro diagnostic field, focus on research and development, concentrate on accumulation, will work with people around the world to defeat the epidemic and build a community with a shared future for human health.
